Diagnostic Performance of CA 125, HE4, and Risk of Ovarian Malignancy Algorithm for Ovarian Cancer

Journal of Clinical Laboratory Analysis - United States
doi 10.1002/jcla.22624
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Risk of Ovarian Malignancy Algorithm

2018English

HE4 a Novel Tumour Marker for Ovarian Cancer: Comparison With CA 125 and ROMA Algorithm in Patients With Gynaecological Diseases

Tumor Biology
MedicineCancer Research
2011English

Diagnostic Performance of Serum Human Epididymis Protein 4 (HE4) for Prediction of Malignancy in Ovarian Masses

Asian Pacific Journal of Cancer Prevention
2019English

EP25.09: Comparison of Diagnostic Value of Using GIRADS System and Ovarian Malignancy Marker Ca-125 in the Preoperational Adnexal Tumours Assessment

Ultrasound in Obstetrics and Gynecology
Nuclear MedicineRadiologyUltrasound TechnologyGynecologyReproductive MedicineRadiologicalImagingObstetricsMedicine
2017English

The Role of CA‐125 in the Management of Ovarian Cancer

Oncologist
Cancer ResearchMedicineOncology
1997English

Risk of Diagnosis of Ovarian Cancer After Raised Serum CA 125 Concentration: A Prospective Cohort Study

BMJ
1996English

Nadir CA-125 Level as Prognosis Indicator of High-Grade Serous Ovarian Cancer

Journal of Ovarian Research
GynecologyOncologyObstetrics
2013English

The Epidemiology of CA-125 in Women Without Evidence of Ovarian Cancer in the Prostate, Lung, Colorectal and Ovarian Cancer (PLCO) Screening Trial

Gynecologic Oncology
GynecologyOncologyObstetrics
2008English

The Use of HE4, CA125 and CA72-4 Biomarkers for Differential Diagnosis Between Ovarian Endometrioma and Epithelial Ovarian Cancer

Journal of Ovarian Research
GynecologyOncologyObstetrics
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy